CTRI/2018/11/016365招募中4 期
A phase IV,double blind,comparative,Prospective,Multicentric study to assess safety and efficacy of fixed dose combination of clindamycin 100 mg and Clotrimazole 100 mg Vaginal suppositories (clingen) VS. Clotrimazole 100 mg vaginal suppositories in patients with mixed vaginal infection
Aristo Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Females 18 years of age or older.
- •2.Women with regular menstruation and visiting the trial centre from 5th day to 20th day of the cycle or post menopausal women (defined as women with absence of menstruation for at least 1 year from the date of screening.), or women with surgical menopause (oophorectomy, hysterectomy).
- •3. Female subjects screened positive for mixed vaginal infection based on two or more of the following microscopic findings
- •1)Yeasts or pseudohyphae on wet preparation (40 ââ?¬â?? 60% sensitivity) of vaginal discharge. ââ?¬â?? and/or Yeasts or pseudohyphae on Gram stain (up to 65% sensitivity) of vaginal discharge
- •2)Direct observation of the organism (T. vaginalis) by a wet smear (normal saline) or acridine orange stained slide from the posterior vaginal fornix (sensitivity 40-70% cases).
- •3)A Gram stain slide with Nugent score more than equal to 4.
- •(Amselââ?¬•s Diagnostic Criteria for Bacterial Vaginosis)
- •a) Off-white, thin, homogeneous discharge with little if any inflammation.
- •b) pH of vaginal fluid greater than 4.5, using pH paper that measures from 4.0 to 6.0
- •c) Positive whiff test for amine odour after addition of 10% KOH.
- •d) More than or equal to 20% Clue cells of the total epithelial cells on microscopic examination of the saline/wet mount.
- •4. Subjects who agree to refrain from the use of intra-vaginal products throughout the study (e.g., douches, feminine deodorant sprays, Spermicides, tampons, and diaphragms).
- •5. Capable of giving written informed consent.
- •6. Agree to no intercourse for 8 days from the day of start of treatment.
排除标准
- •1.Pregnant or lactating women.
- •2.Patients receiving neuromuscular blocking agents.
- •3.Patients having history of hypersensitivity to Clindamycin or Clotrimazole.
- •4.Patients with history of regional enteritis, ulcerative colitis, pseudo-membranous colitis or history
- •of antibiotic associated colitis.
- •5.Women receiving any antibiotic treatment 14 days prior to enrolment.
- •6.Female patient of child bearing potential who do not agree to remain abstinent or use medically acceptable methods of contraception during the study therapy.
- •7.Patients who have participated in any clinical trial in the past 3 month.
- •8.History of significant cardiovascular disorders or primary or secondary immunodeficiency.
- •9.Any other condition that in the opinion of the Investigator does not justify the patientââ?¬•s participation in the study.
- •10.Presence of vaginal / vulval ulcer or any other vulval, vaginal or medical condition, including cervical neoplasia/ treatment that might confound treatment response.
- •11.Inability to keep return appointments
- •12.Presence of intrauterine device.
- •13.Patients who do not agree to stop use of any other antibacterial, antifungal or anti protozoal drug during trial period.
研究者
相似试验
已完成
不适用
A phase-IV randomised, double blind comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliomyelitis Vaccine (mOPV1) versus trivalent OPV (tOPV): four-armed studyISRCTN54186735Panacea Biotec Limited (India)720
进行中（未招募）
1 期
Clinical study assessing interchangeability between SB5 and Humira in patients with moderate to severe chronic plaque psoriasis.Moderate to severe plaque psioriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2022-000695-19-LTSamsung Bioepis Co., Ltd366
进行中（未招募）
1 期
Commercial study conducted to determine the most adequate supplementation of vitamin D in patients showing vitamin D deficiencyPatients of 18 years of age or more with vitamin D deficiencyMedDRA version: 14.1Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-004917-14-BEABORATOIRES SMB S.A
进行中（未招募）
1 期
Balneum Plus cream for the Treatment of Itching in Kidney DiseaseEUCTR2014-005594-36-GBPortsmouth Hospitals NHS Trust58
进行中（未招募）
1 期
A pharmacological study on efficacy and safety of OM-85 in children with recurrent respiratory tract infectionsEUCTR2016-002705-19-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO288